Cipla Limited vs Glenmark Pharmaceuticals Limited
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Cipla Limited is the larger company by market value: $12.3 B against $8.1 B for Glenmark Pharmaceuticals Limited, 1.5 times as much (market caps of Nov 20, 2026).
- Cipla Limited had more revenue: $3.0 B against $1.8 B for Glenmark Pharmaceuticals Limited, both in the year to March 2026.
- Cipla Limited earned more: net income of $419 M against $147 M for Glenmark Pharmaceuticals Limited.
- Cipla Limited keeps more of each dollar of sales: a net margin of 14.0% against 8.1% for Glenmark Pharmaceuticals Limited.
- Cipla Limited employs more people: 23,000 against 10,667 at Glenmark Pharmaceuticals Limited. Each employee brings in about $130,097 of revenue at Cipla Limited and $169,163 at Glenmark Pharmaceuticals Limited.
- On price to earnings, Glenmark Pharmaceuticals Limited trades at 54.8× and Cipla Limited at 29.4×: investors pay more for each dollar of Glenmark Pharmaceuticals Limited's profit.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | Cipla Limited CIPLA.BO · #1,863 in the world | Glenmark Pharmaceuticals Limited GLENMARK.BO · #2,545 in the world |
|---|---|---|
| Profile | ||
| Country | 🇮🇳 India | 🇮🇳 India |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 1935 | 1977 |
| Size | ||
| Market cap | $12.3 B | $8.1 B |
| Revenue | $3.0 B | $1.8 B |
| Net income | $419 M▲ best | $147 M |
| Employees | 23,000 | 10,667 |
| Valuation | ||
| P/E ratio | 29.4× | 54.8× |
| Price to sales | 4.1× | 4.5× |
| Price to book | 3.3× | 7.1× |
| Altman Z-score zone | — | — |
| Data as of | Market cap Nov 2026 | Market cap Nov 2026 |
Questions and answers#
Which is bigger, Cipla Limited or Glenmark Pharmaceuticals Limited?
Cipla Limited is the larger company by market value: $12.3 B against $8.1 B for Glenmark Pharmaceuticals Limited, 1.5 times as much (market caps of Nov 20, 2026).
Which makes more money, Cipla Limited or Glenmark Pharmaceuticals Limited?
Cipla Limited had more revenue: $3.0 B against $1.8 B for Glenmark Pharmaceuticals Limited, both in the year to March 2026. Cipla Limited earned more: net income of $419 M against $147 M for Glenmark Pharmaceuticals Limited.
Which is more profitable, Cipla Limited or Glenmark Pharmaceuticals Limited?
Cipla Limited keeps more of each dollar of sales: a net margin of 14.0% against 8.1% for Glenmark Pharmaceuticals Limited.
Which has more employees, Cipla Limited or Glenmark Pharmaceuticals Limited?
Cipla Limited employs more people: 23,000 against 10,667 at Glenmark Pharmaceuticals Limited. Each employee brings in about $130,097 of revenue at Cipla Limited and $169,163 at Glenmark Pharmaceuticals Limited.
Is Cipla Limited cheaper than Glenmark Pharmaceuticals Limited?
On price to earnings, Glenmark Pharmaceuticals Limited trades at 54.8× and Cipla Limited at 29.4×: investors pay more for each dollar of Glenmark Pharmaceuticals Limited's profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.